Latest Insider Transactions at Mural Oncology PLC (MURA)
This section provides a real-time view of insider transactions for Mural Oncology PLC (MURA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mural Oncology plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mural Oncology plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 07
2024
|
Vicki L Goodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,069
-6.94%
|
$15,207
$3.33 P/Share
|
|
Oct 31
2024
|
Adam D. Cutler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,421
-9.41%
|
$22,263
$3.41 P/Share
|
|
Aug 14
2024
|
Susan Altschuller |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$30,000
$3.21 P/Share
|
|
Jul 18
2024
|
Maiken Keson Brookes |
SELL
Open market or private sale
|
Direct |
2,157
-4.69%
|
$6,471
$3.41 P/Share
|
|
Jul 08
2024
|
Caroline Loew Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,531
-4.95%
|
$25,062
$2.91 P/Share
|
|
Mar 01
2024
|
Caroline Loew Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,475
+16.08%
|
-
|
|
Mar 01
2024
|
Maiken Keson Brookes |
BUY
Grant, award, or other acquisition
|
Direct |
16,800
+26.75%
|
-
|
|
Dec 14
2023
|
Caroline Loew Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
204,447
+50.0%
|
-
|
|
Dec 14
2023
|
Maiken Keson Brookes |
BUY
Grant, award, or other acquisition
|
Direct |
29,207
+50.0%
|
-
|
|
Dec 14
2023
|
Adam D. Cutler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,859
+50.0%
|
-
|
|
Dec 14
2023
|
Vicki L Goodman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,018
+50.0%
|
-
|